Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Regulatory Toxicology and Pharmacology : RTP|May 3, 2003
Dioxin risks in perspective: past, present, and futureSean M Hays, Lesa L AylwardRegulatory Toxicology and Pharmacology : RTP|June 28, 2008
Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1)Sean M Hays, Lesa L AylwardInternational Journal of Hygiene and Environmental Health|March 29, 2011
Biomonitoring-based risk assessment for hexabromocyclododecane (HBCD)Lesa L Aylward, Sean M HaysRegulatory Toxicology and Pharmacology : RTP|June 27, 2008
Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7)Lesa L Aylward, Sean M HaysJournal of Exposure Analysis and Environmental Epidemiology|August 29, 2002
Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levelsLesa L Aylward, Sean M HaysJournal of Applied Toxicology : JAT|March 8, 2011
Consideration of dosimetry in evaluation of ToxCast™ dataLesa L Aylward, Sean M HaysInternational Journal of Hygiene and Environmental Health|December 24, 2011
Interpreting human biomonitoring data in a public health risk context using Biomonitoring EquivalentsSean M Hays, Lesa L AylwardJournal of Applied Toxicology : JAT|December 31, 2008
Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk contextSean M Hays, Lesa L AylwardJournal of Exposure Science & Environmental Epidemiology|August 18, 2011
Urinary DEHP metabolites and fasting time in NHANESLesa L Aylward, Matthew Lorber, Sean M HaysJournal of Exposure Science & Environmental Epidemiology|October 6, 2016
Variation in urinary spot sample, 24 h samples, and longer-term average urinary concentrations of short-lived environmental chemicals: implications for exposure assessment and reverse dosimetryLesa L Aylward, Sean M Hays, Angelika ZidekPageof 13